Online:
Visits:
Stories:
Profile image
By Free North Carolina
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Second US Ebola Patient, Treated With ZMapp Experimental Drug, Leaves For Atlanta

Tuesday, August 5, 2014 12:44
% of readers think this story is Fact. Add your two cents.

(Before It's News)

 Ebola outbreak

Dr. Kent Brantly, who is being treated with an experimental drug for the Ebola virus at Atlanta's Emory University Hospital, will soon be joined by the second American to have contracted the virus.

The drug ZMapp, made by Mapp Biopharmaceutical Inc., of San Diego, has been identified as a potential treatment for the disease but had never been tested on a human until now. The second patient, Nancy Writebol, who left for Atlanta from Monrovia, Liberia, on Tuesday, has started recovering from the disease after receiving two doses of the drug before leaving for the U.S., according to the Associated Press, or AP. ZMapp was developed by a long-running research program supported by the U.S. government and its military.



Source: http://freenorthcarolina.blogspot.com/2014/08/second-us-ebola-patient-treated-with.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.